V.V.T. MED LTD

V.V.T. Med Ltd specializes in sclerotherapy devices, specifically dual injection/aspiration catheters. These catheters are designed for vascular procedures, such as endovenous treatments, where controlled delivery of sclerosing agents is required to address venous conditions. Examples include the SclereSafe, ScleroSafe (variants like 150mm and 350mm), VBlock (45cm and 65cm), and the DPS.

V.V.T. Med Ltd is based in Israel. The company’s primary focus is on developing and manufacturing sclerotherapy catheters, which are medical devices used in the treatment of venous diseases by delivering sclerosing agents directly into varicose or abnormal veins.

V.V.T. Med Ltd’s devices are registered in the EU’s EUDAMED database, which tracks medical devices under the EU Medical Device Regulations. Additionally, their products are listed in the FDA’s Unique Device Identifier (UDI) system, ensuring traceability and compliance in the United States.

Under the EU Medical Device Regulations, V.V.T. Med Ltd’s devices fall into Class II, Class IIa, and Class IIb classifications. These classifications indicate varying levels of risk, with Class IIa representing moderate risk and Class II/IIb indicating higher risk due to their role in treating vascular conditions where precision and safety are critical.